A new class of antiemetic agents on the horizon

Clin J Oncol Nurs. 2002 Mar-Apr;6(2):103-4. doi: 10.1188/02.CJON.103-104.

Abstract

This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.

Publication types

  • Review

MeSH terms

  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Humans
  • Nausea / chemically induced*
  • Nausea / prevention & control*
  • Neurokinin-1 Receptor Antagonists*
  • Vomiting / chemically induced*
  • Vomiting / prevention & control*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Neurokinin-1 Receptor Antagonists